Intersocietal Accreditation Commission (IAC)’s release of new standards accepting ultra-low-field MRI technology enables accredited facilities to qualify for reimbursement from the US Centers for ...

New dementia study actively enrolling and new data to be presented at the 2025 Alzheimer's Association International Conference. GUILFORD, Conn.--(BUSINESS WIRE)-- Hyperfine, Inc. (HYPR) (Nasdaq: HYPR ...

The next-generation Swoop® scanner, which was cleared by the FDA in the second quarter of 2025, represents a significant advancement in portable brain MRI, delivering substantial improvements in image ...

Following the recent clearance of the new Swoop® System, two leading hospitals in the United States have purchased the first commercial units, marking the launch of next-generation portable MR brain ...

India's Central Drugs Standard Control Organization (CDSCO) has approved the Hyperfine Swoop system, opening a major global market. Commercial launch to begin early 2026. GUILFORD, Conn.--(BUSINESS ...

GUILFORD, Conn., Feb. 06, 2023 (GLOBE NEWSWIRE) -- Hyperfine, Inc., creator of the Swoop® Point-of-Care MRI System™ for imaging of the brain, today announced the acceptance of twelve abstracts related ...

GUILFORD, Conn., Feb. 21, 2023 (GLOBE NEWSWIRE) -- Hyperfine, Inc. (Nasdaq: HYPR), the groundbreaking medical device company that created the Swoop ® system, the world's first FDA-cleared portable MRI ...

Hyperfine Announces Enrollment of First Patient in Study to Expand Intended Use of the Swoop® System with Contrast Agents The prospective study is designed to evaluate the feasibility and ...

GUILFORD, Conn.--(BUSINESS WIRE)--Hyperfine, Inc. (Nasdaq: HYPR), the groundbreaking health technology company that has redefined brain imaging with the first FDA-cleared portable magnetic resonance ...

The MarketWatch News Department was not involved in the creation of this content. This milestone unlocks Hyperfine's most significant technology innovations to date for clinicians and patients across ...